Gondolabio Gets FDA Orphan Drug, Fast Track For PORT-77
21 Oct 2025 //
BUSINESSWIRE
GondolaBio & n-Lorem Partner on ASO Therapies for Genetic Disease
17 Dec 2024 //
BUSINESSWIRE
BridgeBio Launches GondolaBio With $300M, Transfers Programs
22 Aug 2024 //
BIOSPACE

Market Place
Sourcing Support